netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

Chapter Links...
 Details...
02.08.01  Expand sub section  Parenteral anticoagulants
Argatroban injection
View adult BNF View SPC online
Formulary

For use under the supervision of a Consultant Haematologist

For anticoagulation in patients with HIT type 2 undergoing cardiac surgery or have renal failure in a HDU/ITU setting who are not suitable for treatment with fondaparinux

 
   
Defibrotide infusion
Unlicensed Drug Unlicensed
Red
High Cost Medicine
BlueTeq

USE UNDER SPECIALIST SUPERVISION ONLY Treatment of patients with severe veno-occlusive disease following stem cell transplant in line with NHS England Clinical Commissioning Policy B04/P/c

 
Link  NHS England Clinical Commissioning Policy B04/P/c: Defibrotide in severe venoocclusive disease following stem cell transplant
   
02.08.01  Expand sub section  Heparin
Heparin injection
View adult BNF View SPC online
Formulary  
   
02.08.01  Expand sub section  Low molecular weight heparins
Enoxaparin injection
View adult BNF View SPC online
Formulary
Amber 2
 
Link  South East London Guidance for Prescribing Enoxaparin in primary care
   
Dalteparin injection
View adult BNF View SPC online
Formulary
Red
First-line LMWH at GSTFT 
   
02.08.01  Expand sub section  Hirudins
Bivalirudin injection
View adult BNF View SPC online
Formulary
Red
 
Link  NICE CG94: Unstable angina and NSTEMI
Link  NICE TA230 : Bivalirudin for the treatment of STEMI, 2011
   
02.08.01  Expand sub section  Epoprostenol to top
Epoprostenol injection
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
USE ON SPECIALIST ADVICE ONLY 
   
02.08.01  Expand sub section  Fondaparinux
Fondaparinux injection
View adult BNF View SPC online
Formulary
Red

Use in accordance with NICE CG92: Venousthromboembolism: reducing the risk

 

Approved off-label indication:

First-line parenteral anticoagulant in adult patients with HIT and patients with an allergy to heparin

Use in accordance with local guideline

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary